King W - Search Results

1

An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy.

Elsheikh B, Prior T, Zhang X, Miller R, Kolb SJ, Moore D, Bradley W, Barohn R, Bryan W, Gelinas D, Iannaccone S, Leshner R, Mendell JR, Mendoza M, Russman B, Smith S, King W, Kissel JT. Elsheikh B, et al. Among authors: king w. Muscle Nerve. 2009 Oct;40(4):652-6. doi: 10.1002/mus.21350. Muscle Nerve. 2009. PMID: 19760790

2

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.

Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Robison J, King W, et al. Fenichel GM, et al. Among authors: king w. Neurology. 1991 Dec;41(12):1874-7. doi: 10.1212/wnl.41.12.1874. Neurology. 1991. PMID: 1745340 Clinical Trial.

3

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.

Fenichel GM, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L, et al. Fenichel GM, et al. Among authors: king w. Arch Neurol. 1991 Jun;48(6):575-9. doi: 10.1001/archneur.1991.00530180027012. Arch Neurol. 1991. PMID: 2039377 Clinical Trial.

4

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.

Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, et al. Mendell JR, et al. Among authors: king w. N Engl J Med. 1989 Jun 15;320(24):1592-7. doi: 10.1056/NEJM198906153202405. N Engl J Med. 1989. PMID: 2657428 Clinical Trial.

5

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, King WM, Pandya S, Robison J, Schierbecker J, et al. Brooke MH, et al. Among authors: king wm. Neurology. 1989 Apr;39(4):475-81. doi: 10.1212/wnl.39.4.475. Neurology. 1989. PMID: 2927672

6

Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, et al. Mendell JR, et al. Among authors: king w. N Engl J Med. 1995 Sep 28;333(13):832-8. doi: 10.1056/NEJM199509283331303. N Engl J Med. 1995. PMID: 7651473 Free article. Clinical Trial.

7

Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.

Winnard AV, Klein CJ, Coovert DD, Prior T, Papp A, Snyder P, Bulman DE, Ray PN, McAndrew P, King W, et al. Winnard AV, et al. Among authors: king w. Hum Mol Genet. 1993 Jun;2(6):737-44. doi: 10.1093/hmg/2.6.737. Hum Mol Genet. 1993. PMID: 8353493

8

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D. Tawil R, et al. Among authors: king w. Ann Neurol. 1996 Jun;39(6):744-8. doi: 10.1002/ana.410390610. Ann Neurol. 1996. PMID: 8651646

9

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC. Tawil R, et al. Among authors: king w. Neurology. 1997 Jan;48(1):46-9. doi: 10.1212/wnl.48.1.46. Neurology. 1997. PMID: 9008492

10

Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R. Kissel JT, et al. Among authors: king wm. Neurology. 1998 May;50(5):1402-6. doi: 10.1212/wnl.50.5.1402. Neurology. 1998. PMID: 9595995 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters